Area of research
Hepatology · Epidemiology
Research interest
Research interests include Liver Diseases and Immunity, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation, and Hepatitis B Virus Studies.
Health-related quality of life is impaired in people with autoimmune hepatitis: Results of a multicentre cross-sectional study within the European Reference Network
Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis
Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R‐LIVER)
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
Treating hepatitis D with bulevirtide – Real-world experience from 114 patients
Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22
Multicytokine-producing CD4+ T cells characterize the livers of patients with NASH
EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study
FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group
Molecular consequences of SARS-CoV-2 liver tropism
Consensus recommendations for histological criteria of autoimmune hepatitis from the International <scp>AIH</scp> Pathology Group
Persistent SOMAtic symptoms ACROSS diseases — from risk factors to modification: scientific framework and overarching protocol of the interdisciplinary SOMACROSS research unit (RU 5211)
Disturbed lipid and amino acid metabolisms in COVID-19 patients
Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure
A prospective pilot study of a gluten‐free diet for primary sclerosing cholangitis and associated colitis
Bulevirtide treatment of hepatitis D in Germany: multicentre real-world experience
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease
Clonal expansion and activation of tissue-resident memory-like T <sub>H</sub> 17 cells expressing GM-CSF in the lungs of patients with severe COVID-19
Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4+ T cells in primary sclerosing cholangitis
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis
Second-line and third-line therapy for autoimmune hepatitis: A position statement from the European Reference Network on Hepatological Diseases and the International Autoimmune Hepatitis Group
Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E – The HepNet SofE pilot study
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation